GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Guanhao Biotech Co Ltd (SZSE:300238) » Definitions » Gross Margin %

Guanhao Biotech Co (SZSE:300238) Gross Margin % : 78.05% (As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Guanhao Biotech Co Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Guanhao Biotech Co's Gross Profit for the three months ended in Mar. 2024 was ¥71.4 Mil. Guanhao Biotech Co's Revenue for the three months ended in Mar. 2024 was ¥91.4 Mil. Therefore, Guanhao Biotech Co's Gross Margin % for the quarter that ended in Mar. 2024 was 78.05%.


The historical rank and industry rank for Guanhao Biotech Co's Gross Margin % or its related term are showing as below:

SZSE:300238' s Gross Margin % Range Over the Past 10 Years
Min: 67.7   Med: 75.68   Max: 88.38
Current: 79.41


During the past 13 years, the highest Gross Margin % of Guanhao Biotech Co was 88.38%. The lowest was 67.70%. And the median was 75.68%.

SZSE:300238's Gross Margin % is ranked better than
73.97% of 749 companies
in the Biotechnology industry
Industry Median: 60.63 vs SZSE:300238: 79.41

Guanhao Biotech Co had a gross margin of 78.05% for the quarter that ended in Mar. 2024 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Guanhao Biotech Co was 2.40% per year.


Guanhao Biotech Co Gross Margin % Historical Data

The historical data trend for Guanhao Biotech Co's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guanhao Biotech Co Gross Margin % Chart

Guanhao Biotech Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 67.70 72.53 75.11 76.25 79.13

Guanhao Biotech Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 77.28 77.96 86.49 74.93 78.05

Competitive Comparison of Guanhao Biotech Co's Gross Margin %

For the Biotechnology subindustry, Guanhao Biotech Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Guanhao Biotech Co's Gross Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Guanhao Biotech Co's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Guanhao Biotech Co's Gross Margin % falls into.



Guanhao Biotech Co Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Guanhao Biotech Co's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=319.8 / 404.179
=(Revenue - Cost of Goods Sold) / Revenue
=(404.179 - 84.367) / 404.179
=79.13 %

Guanhao Biotech Co's Gross Margin for the quarter that ended in Mar. 2024 is calculated as


Gross Margin % (Q: Mar. 2024 )=Gross Profit (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=71.4 / 91.441
=(Revenue - Cost of Goods Sold) / Revenue
=(91.441 - 20.071) / 91.441
=78.05 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Guanhao Biotech Co  (SZSE:300238) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Guanhao Biotech Co had a gross margin of 78.05% for the quarter that ended in Mar. 2024 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Guanhao Biotech Co Gross Margin % Related Terms

Thank you for viewing the detailed overview of Guanhao Biotech Co's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Guanhao Biotech Co (SZSE:300238) Business Description

Traded in Other Exchanges
N/A
Address
No.12 Yuyan Road, Luogang District, Guangdong, Guangzhou, CHN, 510530
Guanhao Biotech Co Ltd is a China-based biotech company. It develops, manufactures and markets life and health-related products, with focus on regenerative medicines for the treatment of damaged tissue and organs. Its products include NormalGEN dura repair patch, GrandNeuro (Type B) dura repair patch, ThromalGEN (Type P) surgical patch, Guanhao-ACI, among others.
Executives
Liu De Wang Directors, executives
Zhao Jun Hui Directors, executives
Yang Guo Sheng Supervisors
Zhu Wei Ping Director
Hu Jun Securities Affairs Representative
Jia Bao Rong Executives
Jia Jun Chao Executives
Di Pu Director
Zhuo Fu Min Director
Guo Xiao Ming Executives
Zhang Hong Tao Executives
Zhao Wen Jie Executives
Guan Xin Director

Guanhao Biotech Co (SZSE:300238) Headlines

No Headlines